GREENLAND MINES LTD Impairment of Intangible Assets (Excluding Goodwill)
GREENLAND MINES LTD (GRML) reported Impairment of Intangible Assets (Excluding Goodwill) of $2.05 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2026-08-17
- GREENLAND MINES LTD impairment of intangible assets (excluding goodwill) for the quarter ending 2026-06-30 was $0.00.
- GREENLAND MINES LTD impairment of intangible assets (excluding goodwill) for the quarter ending 2026-03-31 was $2.05M.
- GREENLAND MINES LTD impairment of intangible assets (excluding goodwill) for fiscal 2024 was $10.00K.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 3 month | Impairment of Intangible Assets (Excluding Goodwill) 6 month | Impairment of Intangible Assets (Excluding Goodwill) 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-08-17 | $2.05M 10-Q · filed 2026-08-17 | |
| 2026-03-31 | $2.05M 10-Q/A · filed 2026-08-14 | ||
| 2024-12-31 | $10.00K 10-K/A · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |